CDKN2A and tuberculosis: TN and TB mice were topically treated with 4-hydroxytamoxifen (4OHT) on postnatal days 1 and 2 to induce Cre activity and stimulate recombination of the conditional p16INK4a knockout and LSL-Nras61R or BrafCA alleles.